Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Provided By GlobeNewswire
Last update: Apr 16, 2025
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes
Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company’s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025
Read more at globenewswire.comNASDAQ:VANI (9/12/2025, 8:23:15 PM)
1.21
+0.01 (+0.83%)
Find more stocks in the Stock Screener
